Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Nifty Pharma index drops 3% as US tariff fears hit Sun Pharma, peers
A Bloomberg report indicated that the Trump administration is planning tariffs on pharmaceutical companies that have not entered into agreements to ensure lower drug prices in the US.
Stock to buy: Jefferies lists 10 reasons to buy its top CRDMO pick Sai Life Sciences
Jefferies has initiated coverage on Sai Life Sciences with a 'Buy' rating and a Rs 1,300 target price, citing its integrated 'follow-the-molecule' model and strong growth outlook. The brokerage highlighted the company's healthy pipeline, global presence, and clean balance sheet as key investment drivers, projecting significant upside potential.
Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories sees a healthy return
Sensex tanks 1,342 pts, Nifty below 23,900 as geopolitical tensions weigh
The key equity benchmarks ended with sharp losses on Wednesday, dragged down by selling in select heavyweights. Geopolitical tensions in the Middle East, particularly the ongoing US-Iran conflict, continued to weigh on market sentiment. Despite earlier expectations that the conflict might end soon, the situation in the region remains tense. Sustained selling by overseas investors over the past several sessions also pressured the market, while the rupee weakened further against the dollar. The Nifty ended below the 23,900 level, led by declines in auto, private bank and financial stocks. However, pharma and healthcare stocks bucked the broader weak market trend.
Sensex nosedives 1,342 pts; Nifty sinks below 23,900 level; VIX jumps 11.41%
Nifty ended below the 23,900 level. Auto, private bank and financial services shares declined, while pharma, oil & gas shares and healthcare shares advanced.
Indian soft drinks industry well-positioned for healthy recovery, non-fizz drinks gain traction: VBL
This year marks a vibrant rebound for the Indian soft drinks sector, where consumer tastes are expanding. Carbonated beverages continue to dominate, yet there's a noticeable shift towards refreshing non-carbonated and juice-infused drinks. Companies are getting creative, focusing on low-sugar and naturally sourced ingredients to entice health-conscious consumers.
Sensex crash over 2,235 in early trade; VIX surges 20.82%
The Nifty traded below the 23,750 mark. All sectoral indices on the NSE were traded in the red, with PSU bank, auto and healthcare shares declining the most.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 9 March 2026
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — Aditya Birla Sun Life Amc, Aster DM Healthcare, CG Power and Industrial Solutions, Astral, and Krishna Institute Of Medical Sciencs.
India hospitality sector revenue to grow 9-12% in 2025-26: Icra Report
The hospitality sector in India is gearing up for a robust surge in revenue, estimated at 9-12% growth by 2025-26. This optimistic forecast stems from a consistent influx of domestic tourists, thriving business conferences, extravagant weddings, and a healthy demand from corporate clients.
Novo Holdings scales up India bets with bigger cheques, focus on mature healthcare assets
The life sciences investor is increasing ticket sizes and doubling down on speciality care and healthcare services as India emerges as a key deployment market in Asia.
Nifty Pharma index soars 7% thus far in February; nears 52-week high
Thus far in the month of February 2026, Laurus Labs surged 13%, while Sun Pharmaceutical Industries and Torrent Pharmaceuticals soared 11% each.
Elara Securities bets on pharma revival; picks Zydus Life, Sun Pharma, Aurobindo Pharma
Bino Pathiparampil, Head of Research at Elara Securities believes the broader pharma space is entering a more favourable phase as pricing concerns and regulatory worries ease while currency movements provide an additional boost.